GLI1 and myeloid leukemia: The expression of Hh signaling proteins, including SMO and GLI1 in radiation-resistance myeloid leukemia cells, are higher than that observed in radiation-sensitive myeloid leukemia cells, suggesting that Hh pathway activation is related to radiotherapy resistance [32].